As direct targeting of MYC in cancer thus far has been unsuccessful because of its complex structure and pleiotropic functions, the identification of key cofactors for MYC to target at transcriptional or translational levels has emerged as a promising alternative for the indirect inhibition of MYC [52,53]. Here, MYC is linked to cancer.